EVALUATION OF RIGHT VENTRICLE SYSTOLIC AND DIASTOLIC FUNCTION IN PATIENTS WITH PAROXYSMAL ATRIAL FIBRILLATION

Bilal Cuglan, Necip Ermis, Ertan Yetkin, Yasin Karakus, Ertugrul Kurtoglu, Ramazan Ozdemir

Abstract


Objective: Atrial fibrillation (AF) is frequently an electrical sign of underlying structural heart disease. Structural remodelling may begin not only in ventricles but also in atrium secondary to AF. In this study, we sought to investigate the effect of paroxysmal atrial fibrillation (PAF) on right ventricle function.

Method: We prospectively analyzed 30 patients diagnosed with PAF and 25 control individuals. Cardiac risk factors and medical treatment of patients were obtained and recorded in both groups. Right ventricle tricuspid annular plane systolic excursion (TAPSE) and Tei indexes were measured as an indicator of right ventricular function.

Results: There was no statistical difference between groups in terms of demographic and clinical characteristics. Tei index was higher and TAPSE was lower in PAF group compared to control individuals (p>0.05). There was no statistically significant difference between PAF and control groups in terms of right ventricular diastolic functions neither. Although isovolumic relaxation time (IVRT) was higher in PAF group, it did not give statistical significance.

Conclusion: In this study, even not being statistically significant Tei index, which assess right ventricular function was over upper limit in PAF patients. This may have been as the result of prolonged IVRT. This result may indicate that right ventricular diastolic functions may be effected in patients with PAF.


Keywords


Atrial Fibrillation, Right Ventricle, 2D Echocardiography

Full Text:

PDF

References


Zoni-Berisso M, Lercari F, Carazza T, Domenicucci S. Epidemiology of atrial fibrillation: European perspective. Clin Epidemiol. 2014;6:213-20.

Wilke T, Groth A, Mueller S, Pfannkuche M, Verheyen F, Linder R, et al. Incidence and prevalence of atrial fibrillation: an analysis based on 8.3 million patients. Europace. 2013;15(4):486-93.

Vaziri SM, Larson MG, Benjamin EJ, Levy D. Echocardiographic predictors of nonrheumatic atrial fibrillation. The Framingham Heart Study. Circulation. 1994;89(2):724-30.

Denham NC, Pearman CM, Caldwell JL, Madders GW, Eisner DA, Trafford AW, et al. Calcium in the pathophysiology of atrial fibrillation and heart failure. Front Physiol. 2018;9:1380.

Prabhu S, Voskoboinik A, Kaye DM, Kistler PM. Atrial fibrillation and heart failure—cause or effect? Heart Lung Circ. 2017;26(9):967-74.

Calkins H, Hindricks G, Cappato R, Kim YH, Saad EB, Aguinaga L, et al. 2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation. Europace. 2018;20(1):e1-e160.

Floria M, Blommaert D, Lacrosse M, Ambarus V, Dormal F, Dabiri Abkenari L, et al. Assessment of left atrial shape and volume in structural remodeling secondary to atrial fibrillation. Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing. 2009;25(3):167-70.

Sarvari SI, Haugaa KH, Stokke TM, Ansari HZ, Leren IS, Hegbom F, et al. Strain echocardiographic assessment of left atrial function predicts recurrence of atrial fibrillation. Eur Heart J Cardiovasc Imaging. 2016;17(6):660-7.

Jurin I, Hadzibegovic I, Durlen I, Jaksić Jurinjak S, Misković D, Ajduk M, et al. Left atrium size and red cell distribution width predict atrial fibrillation progression from paroxysmal or persistent to permanent. Acta Clinica Belgica. 2020;75(3):205-11.

Houltz B, Johansson B, Berglin E, Karlsson T, Edvardsson N, Wandt B. Left ventricular diastolic function and right atrial size are important rhythm outcome predictors after intraoperative ablation for atrial fibrillation. Echocardiography. 2010;27(8):961-8.

Donal E, Lip GY, Galderisi M, Goette A, Shah D, Marwan M, et al. EACVI/EHRA Expert Consensus Document on the role of multi-modality imaging for the evaluation of patients with atrial fibrillation. Eur Heart J Cardiovasc Imaging. 2016;17(4):355-83.

Lang RM, Badano LP, Mor-Avi V, Afilalo J, Armstrong A, Ernande L, et al. Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr. 2015;28(1):1-39.e14.

Rudski LG, Lai WW, Afilalo J, Hua L, Handschumacher MD, Chandrasekaran K, et al. Guidelines for the echocardiographic assessment of the right heart in adults: a report from the American Society of Echocardiography endorsed by the European Association of Echocardiography, a registered branch of the European Society of Cardiology, and the Canadian Society of Echocardiography. J Am Soc Echocardiogr. 2010;23(7):685-713.

Eidem BW, O'Leary PW, Tei C, Seward JB. Usefulness of the myocardial performance index for assessing right ventricular function in congenital heart disease. Am J Cardiol. 2000;86(6):654-8.

Ozben B, Basaran Y. [Echocardiography and other imaging modalities in pulmonary arterial hypertension]. Anadolu Kardiyol Derg. 2010;10 (Suppl 1):27-35.

Yücel M, Alp H, Yorulmaz A, Karaarslan S, Baysal T. Prediction of the development of pulmonary arterial hypertension with Tei Index in congenital heart diseases with left-to-right shunt. Turk Kardiyol Dern Ars. 2019;47(6):466-75.

Giusca S, Popa E, Amzulescu MS, Ghiorghiu I, Coman IM, Popescu BA, et al. Is right ventricular remodeling in pulmonary hypertension dependent on etiology? An echocardiographic study. Echocardiography. 2016;33(4):546-54.

Field ME, Solomon SD, Lewis EF, Kramer DB, Baughman KL, Stevenson LW, et al. Right ventricular dysfunction and adverse outcome in patients with advanced heart failure. J Card Fail. 2006;12(8):616-20.

Kavousi M. Differences in epidemiology and risk factors for atrial fibrillation between women and men. Front Cardiovasc Med. 2020;7:3.

O'Neal WT, Soliman EZ, Qureshi W, Alonso A, Heckbert SR, Herrington D. Sustained pre–hypertensive blood pressure and incident atrial fibrillation: the Multi–Ethnic Study of Atherosclerosis. J Am Soc Hypertens. 2015;9(3):191-6.

Acar G, Akcay A, Dogan E, Isik IO, Sokmen A, Sokmen G, et al. The prevalence and predictors of atrial fibrillation in hemodialysis patients. Turk Kardiyol Dern Ars. 2010;38(1):8-13.




DOI: http://dx.doi.org/10.24125/sanamed.v15i2.417

Refbacks

  • There are currently no refbacks.


Copyright (c) 2020 bilal cuglan

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.